TARDBP and Parkinson disease: This is evidenced by the accumulation of β-amyloid, tau, α-synuclein, and TDP-43 in the brains of individuals with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, respectively78.